COMMUNIQUÉS West-GlobeNewswire

NeuroMetrix Reports Q4 and Full Year 2018 Financial Results
24/01/2019
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2018. The Company develops and markets [...]
Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
24/01/2019
FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Auxly Signs Definitive Agreement With Curative Cannabis
24/01/2019
VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the " Company ") is pleased to announce that the Company has signed a definitive agreement (the “ [...]
Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of Directors
24/01/2019
GAITHERSBURG, Md., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Robert G. Kramer, Sr. to the company’s Board of Directors. Mr. Kramer currently serves as [...]
Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors
24/01/2019
CAMBRIDGE, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
Invitation to C-RAD Web Presentation Year-end Report 2018
24/01/2019
Presentation of the report for the fiscal year 2018: Date: Friday February 8, 2019 / kl. 13:00 CET Venue: Online Presentation Topic: C-RAD Year-end Report 2018 Procedure: Please register online through the website: [...]
FIT Biotech Oy: FIT Biotech plans a reverse share split
24/01/2019
FIT Biotech Oy Company release 24.1.2019 at 09:20 am EET FIT Biotech plans a reverse share split FIT Biotech Oy ("Company", FITBIO: FN Finland) plans to reduce the number of all its shares through a reverse share split [...]
Annual report 2018
24/01/2019
Please see attached file Attachment The_Novozymes_Report_2018
Group financial statement for 2018
24/01/2019
Read the full announcement in PDF Attachment 2019_01_Q42018_CompanyAnnouncement_EN_FINAL
Succès du traitement par bermekimab de l’hidrasadénite suppurée, avec notamment une nette diminution des douleurs
24/01/2019
Bermekimab traite les patients atteints d’hidrasadénite suppurée, même ceux en échec par un traitement biologique avancé AUSTIN, Texas, 24 janv. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui [...]
Bavarian Nordic Advances Development of Equine Encephalitis Virus Vaccine
24/01/2019
COPENHAGEN, Denmark, January 24, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) reports further progress in the development of a prophylactic vaccine against the equine encephalitis virus - a rare, but potentially [...]
Basilea announces collaboration to study derazantinib and atezolizumab (Tecentriq®) in urothelial cancer
24/01/2019
Basel, Switzerland, January 24, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore a combination of Basilea's derazantinib and Roche's [...]
MDxHealth (R): SelectMDx Outperforms Prostate Health Index (phi) Blood Test for Detecting High-Grade Prostate Cancer
24/01/2019
NEWS RELEASE REGULATED INFORMATION Data to be presented at the 29th Annual IPCU meeting Beaver Creek, Co, January 24-27, 2019 IRVINE, CA, and HERSTAL, BELGIUM - January 24, 2019 - MDxHealth SA (Euronext: MDXH.BR) today [...]
MDxHealth (R) : Le test SelectMDx est plus performant que le test sanguin PHi dans la détection du cancer de la prostate de haut grade
24/01/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Les données seront présentées lors de la 29 e conférence annuelle IPCU qui se tiendra à Beaver Creek, Colorado, du 24 au 27 janvier 2019. IRVINE, CALIFORNIE, et HERSTAL, [...]
Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
24/01/2019
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX, “Telix”) today announced [...]
Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019
23/01/2019
Previously announced merger with NeuBase Therapeutics remains on track NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (Nasdaq: OHRP) announced today that its board of [...]
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
23/01/2019
CAMBRIDGE, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019
23/01/2019
BILLERICA, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019, at 4:30 p.m. Eastern Time to discuss its financial results [...]
HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program
23/01/2019
TUCSON, Ariz., Jan. 23, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph [...]

Pages